Alternative Pneumoconiosis Treatment Offered at the Lung Institute
Common pneumoconiosis treatment options include medications, lifestyle changes and activity modifications. Even though this condition, which is also known as black lung disease, cannot be cured, many people are able to manage their symptoms by using supplemental oxygen, taking prescription medications to keep their lung passages open and avoiding tobacco products and dust exposure.
A newer, innovative pneumoconiosis treatment option is cellular therapy, in which a patient’s own cells are used to help reduce inflammation and promote healing. Unlike some other treatments, cellular therapy has the potential to slow the progression of the disease. Many people who undergo cellular therapy for pneumoconiosis report not only an improvement in their quality of life, but also a reduced dependence on medications and supplemental oxygen. At the Lung Institute, we offer cellular therapy as pneumoconiosis treatment. In our Blood-Derived Therapy, the cells are taken from the patient’s blood. Autologous cell procedures are performed on an outpatient basis over the course of two days and consist of three simple steps:
- Our experienced medical professionals take a blood sample from the patient
- In our onsite lab, we separate out the cells
- We return the concentrated cells to the patient’s body, and after a short monitoring period, the patient can return to the hotel accommodations
We are committed to helping each patient achieve the best possible outcome for his or her pneumoconiosis treatment. After the procedure, our medical team conducts comprehensive follow-up care and coordinates with the other members of the patient’s treatment team, including his or her primary care physician and pulmonologist.
For more information about cellular therapy as an alternative pneumoconiosis treatment, or for more facts about black lung disease, call the Lung Institute at (800) 729-3065. Our dedicated staff can help you determine if cellular therapy may be right for you.